Related Experiment Video

Updated: Aug 7, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

[Neuroprotective effect of the long-term beta-interferon course in multiple sclerosis: direct and indirect

E I Gusev, A N Boĭko, N V Khachanova

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |July 18, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    Related Concept Videos

    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

    Articles linked to this work by shared authors, journal, and citation graph.

    [Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Results of the implementation of reperfusion technologies in ischemic stroke].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

    [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

    [Botulinum therapy within a three-stage medical rehabilitation framework for patients with disorders of craniofacial muscles].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Modern approaches to the medical rehabilitation of stroke patients].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Use of a rehabilitation glove in the acute phase of ischemic stroke in patients with moderate arm paresis].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Enhancing medical rehabilitation outcomes for patients following ischemic stroke].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Multicenter ambispective observational study of oral anticoagulants in cerebral venous thrombosis (Eurasian Registry of Cerebral Venous Thrombosis - ER-CVT)].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Success rates of revascularization methods in ischemic stroke in clinical practice].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us